Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data-Reference-Cited by-同舟云学术

Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data

Published:2019-08 Issue:2 Volume:154 Page:441-448
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Cohen Paul A.,Powell Aime,Böhm Steffen,Gilks C. Blake,Stewart Colin J.R.,Meniawy Tarek M.,Bulsara Max,Avril Stefanie,Brockbank Eleanor C.,Bosse Tjalling,de Azevedo Focchi Gustavo Rubino,Ganesan Raji,Glasspool Rosalind M.,Howitt Brooke E.,Kim Hyun-Soo,Lee Jung-Yun^ORCID,Le Nhu D.,Lockley Michelle,Manchanda Ranjit^ORCID,Mandalia Trupti,McCluggage W. Glenn,McNeish Iain,Midha Divya,Srinivasan Radhika^ORCID,Tan Yun Yi,van der Griend Rachael,Yunokawa Mayu^ORCID,Zannoni Gian F.,Singh Naveena,Aggarwal Simi,Bronger Holger,Brown Elizabeth B.,Buck Martin,Bukhari Syed A.,Coghlan Edwina,Cope Nichola,de Almeida Michelle Samora,De Kroon Cornelius D.,Dean Andrew,Devlin Michael-John,Ditzel Helena M.,Drecoll Enken,Ebata Takahiro,Fagotti Anna,Faruqi Asma,Feeney Laura,Gupta Kavita,Harley Ian,Inzani Frediano,Jeyarajah Arjun R.,Koay M.H. Eleanor,Kroep Judith R.,Lee Jung-Yun,Leung Yee,Lockley Michelle,Loft Alice R.,MaGee Daniel,Manchanda Ranjit,McKenna Sarah,Midha Divya,Millan David,Millar Joanne,Miller Rowan,Mohan Ganendra R.,Mughal Sohail,Mukhopadhyay Asima,Nicolau Sergio Mancini,Nevin James,Oakley Abigail S.,Quigley Mary,Rai Bhavana,Rajwanshi Arvind,Salfinger Stuart G.,Scambia Giovanni,Scatchard Kate,Schmalfeldt Barbara,Simcock Bryony,Singh Priya,Strickland Kyle C.,Suri Vainta,Syed Sheeba,Sykes Peter,Tamura Kenji,Tan Adeline,Tan Jason,Thompson Emily,Tinker Anna V.,Trevisan Georgia,Uyeda Maria Gabriela Baumgarten Kuster,Vaughan Michelle M.,Weichert Wilko,Williams Anthony,Williams Sarah,Yoshida Hiroshi,Zorzato Pier Carlo

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference27 articles.

1. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer;Vergote;N. Engl. J. Med.,2010

2. Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial;Kehoe;Lancet,2015

3. Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy;Kuerer;J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol.,1999

4. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations;Mandard;Cancer,1994

5. Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy;Becker;Cancer,2003

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. British Gynaecological Cancer Society (BGCS) ovarian, tubal and primary peritoneal cancer guidelines: Recommendations for practice update 2024;European Journal of Obstetrics & Gynecology and Reproductive Biology;2024-09

2. Correlating the KELIM (CA125 elimination rate constant K) score and the chemo-response score as predictors of chemosensitivity in patients with advanced ovarian carcinoma;Gynecologic Oncology;2024-08

3. External validation of Standardized KELIM and platinum-resistant recurrence scores in patients with advanced epithelial ovarian cancer;Journal of Ovarian Research;2024-07-22

4. The impact of Paclitaxel-based hyperthermic intraperitoneal chemotherapy in advanced high-grade serous ovarian cancer patients - interim analysis of safety and immediate efficacy of a randomized control trial (C-HOC trial);Journal of Ovarian Research;2024-07-12

5. Chemotherapy response assessment using ultrasound in ovarian cancer;Gynecology and Obstetrics Clinical Medicine;2024-07